Summary:
Evanston Premier Healthcare Research is conducting a 12 week study and 6 visits involving an oral GLP added on to metformin background therapy in Type 2 diabetics. Main purpose of the study is to look at change in blood sugar and also change in weight.
Qualified Participants Must:
• Be between 18 and 75 years of age
•
Have Type 2 diabetes
•
Be on at least 1000mg of metformin daily for at least 3 months
Qualified Participants May Receive:
Up to $400 for study participation and Study related medical exams and labs.